Chinese english Germany Japanese Korea

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE Struktur
1434050-99-3
CAS-Nr.
1434050-99-3
Englisch Name:
10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE
Synonyma:
10-bromo-3,4,6,7,8,9-hexahydro-2H-pyrazino[1,2-a]indol-1-one;10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE;Pyrazino[1,2-a]indol-1(2H)-one, 10-bromo-3,4,6,7,8,9-hexahydro-
CBNumber:
CB23861930
Summenformel:
C11H13BrN2O
Molgewicht:
269.14
MOL-Datei:
1434050-99-3.mol
Request For Quotation

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE Eigenschaften

Siedepunkt:
555.0±50.0 °C(Predicted)
Dichte
1.80±0.1 g/cm3(Predicted)
pka
13.95±0.20(Predicted)

Sicherheit

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE Chemische Eigenschaften,Einsatz,Produktion Methoden

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323967 +86-18015559028
 sales1@artkmedchem.com China 39009 58
Chengdu Feibai Pharmaceutical Co., Ltd. 028-84641798 18782128315
 3302391190@qq.com China 9861 55
Xi'an Minze Pharmaceutical Technology Co., Ltd 13981836672
 2560370848@qq.com China 2803 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188
 sun_dan@PharmaBlock.com China 7268 58
Shaoyuan Technology (Shanghai) Co., Ltd. 021-50795510 4000665055
 sy-c6@accelachem.com China 10129 58
  • 10-BROMO-3,4,6,7,8,9-HEXAHYDROPYRAZINO[1,2-A]INDOL-1(2H)-ONE
  • 10-bromo-3,4,6,7,8,9-hexahydro-2H-pyrazino[1,2-a]indol-1-one
  • Pyrazino[1,2-a]indol-1(2H)-one, 10-bromo-3,4,6,7,8,9-hexahydro-
  • 1434050-99-3
Copyright 2019 © ChemicalBook. All rights reserved